Transcatheter aortic valve implantation (TAVI) is an effective way to treat patients with symptomatic aortic stenosis when open surgical repair is not feasible or considered too high risk. Large bore vascular access is required (18F-24F), and successful management of this arterial access is the key to overall procedural success. We review the current state of play with regard to vascular closure following retrograde transfemoral TAVI.
©2012, Wiley Periodicals, Inc.